KRAS and neoplasm: Additionally, SLC7A11 was also found to be essential for tumor growth by relieving oxidative stress in some oncogenic KRAS-mutant cancers, including pancreatic ductal adenocarcinoma, colorectal adenocarcinoma and LUAD [42, 43].